Schrodinger (US:SDGR) — Company Overview, News & Financial Data
Schrodinger develops computational chemistry software to accelerate drug discovery and materials design for life sciences.
Schrodinger
Schrodinger (NASDAQ:SDGR) specializes in developing software for computational chemistry to accelerate drug discovery and materials design. Its innovative platforms leverage physics-based simulations to predict molecular behavior, aiding in the discovery of novel therapeutics and materials. The company collaborates with research institutions and industry leaders to apply its technology across various stages of the R&D process, aiming to streamline development timelines and enhance decision-making in complex scientific projects. Schrodinger's objectives focus on expanding the reach of its computational platforms, fostering partnerships, and contributing to advancements in life sciences and materials science research.
Snapshot
Operations
Products and/or services of Schrodinger
- Drug Discovery Platform, offering integrated computational solutions to discover novel therapeutics.
- Materials Science Solutions, providing advanced simulation capabilities for materials design and development.
- LiveDesign, a collaboration platform enabling real-time scientific project collaboration and decision-making.
- FEP+, a technology for accurate prediction of drug binding affinities.
- QikProp, a software for predicting ADMET properties of potential drug candidates.
- Biologics Suite, offering tools for the design and optimization of biologic therapeutics.
Schrodinger executive team
- Dr. Ramy Farid Ph.D.CEO, President & Director
- Dr. Karen Akinsanya Ph.D.President, Head of Therapeutics R&D and Chief Strategy Officer & Partnerships
- Dr. Richard A. Friesner Ph.D.Co-Founder, Scientific Advisory Chairman and Director
- Mr. Kenneth Patrick LortonExecutive VP, CTO & COO of Software
- Dr. Robert Lorne Abel Ph.D.Executive VP, Chief Scientific Officer of Platform and Head of Modeling R&D
- Prof. William Goddard III, Ph.D.Co-Founder & Scientific Advisor
- Mr. Richie JainExecutive VP, CFO & Treasurer
- Ms. Jenny HermanChief Accounting Officer
- Mr. Shane BraunerExecutive VP & Chief Information Officer
- Ms. Jaren Irene MaddenChief Corporate Affairs Officer & Head of Investor Relations